The etiopathogenesis of type 1 diabetes (T1D), a common autoimmune disorder, is not 19 completely understood. Recent studies suggested the gut microbiome plays a role in T1D. We 20 have used public longitudinal microbiome data from T1D patients to analyze amyloid-21 producing bacterial composition and found a significant association between initially high 22 amyloid-producing Escherichia coli abundance, subsequent E. coli depletion prior to 23 seroconversion, and T1D development. In children who presented seroconversion or developed 24 T1D, we observed an increase in the E. coli phage/E. coli ratio prior to E. coli depletion, 25 suggesting that the decrease in E. coli was due to prophage activation. Evaluation of the role of 26 phages in amyloid release from E. coli biofilms in vitro suggested an indirect role of the 27 bacterial phages in the modulation of host immunity. 28 This study for the first time suggests that amyloid-producing E. coli, their phages, and bacteria-29 derived amyloid might be involved in pro-diabetic pathway activation in children at risk for 30 T1D.
Introduction 35
Type 1 diabetes (T1D) is an autoimmune disorder driven by T cell-mediated destruction of the differently over time, and importantly, data from the control group revealed that there was no 156 variation in E. coli associated with age. or ICA, in case groups. No correlations were observed (data not shown). We also detected no 191 association between E. coli disappearance and breastfeeding duration, Bifidobacterium abundance, 192 or antibiotic usage, which are known to influence Enterobacteriaceae (Tables S5, S6 ) (Candela et 193 al., 2008) . As we identified E. coli as T1D-discriminative bacteria, we next studied the relationships between 197 this microorganism and bacteriophages of E. coli, as phages are known as main regulators of 198 bacterial populations. First, we detected 63 E. coli phage species in case and control groups. We 199 evaluated possible differences in E. coli phages, using α-diversity, in the pre-seroconversion period 200 (Table S7 ). For the samples from the control group, we set the medium time to seroconversion in 201 case groups (540 days) as an artificial benchmark. Phage richness was statistically different 202 between control and seroconversion individuals as indicated by ACE and Chao1 indexes (ACE: p 203 = 0.0181; Chao1: p = 0.0137), but was not statistically significantly different between control and 204 T1D, most likely because of the small T1D patient cohort (ACE: p = 0.6086; Chao1: p = 0.6359).
205
E. coli phage diversity tended to be lower in the control subjects than in seroconverters (Shannon, 206 p = 0.1526; Simpson, p = 0.5437), and was significantly lower in controls vs. T1D cases (Shannon, 207 p = 0.0055; Simpson, p = 0.0248) (Mann-Whitney test) ( Table S7 ).
208
We observed that nearly all E. coli phages were lysogenic, whereas strictly virulent lytic 209 phages, such as Enterobacteria phage IME10 or Enterobacteria phage 9g, were found only in a 210 few samples (Table S2 ). The predominance of lysogenic E. coli phages clarifies why α-diversity 211 indices revealed trends of decreased evenness and diversity of phages in case groups compared to 212 controls in pre-seroconversion samples, which most likely reflected lower E. coli abundance in 213 controls (Table S2) . 214 Next, we analyzed the E. coli phage/E. coli bacterial cell ratio, which represents the "lytic 215 potential" (Figure 4 ; Table S8 ; Table S9 ) (Waller et al., 2014) . To this end, we first normalized 216 the E. coli phage abundance to that of E. coli. In theory, the phage/bacteria ratio reflects whether 217 or not a prophage is stably integrated within the host bacterial genome (Tetz et al., 2018) . A 218 low ratio indicates that prophage is most likely absent in the genomes of part of the bacterial 219 host population, whereas a high ratio suggests active, productive phage-induced bacterial lysis.
220
The phage/bacteria ratio increased in subjects from all groups prior to the decrease in E. coli 221 abundance, indicating that productive phage infection was the cause of E. coli depletion.
222
Notably, that observation reflected a statistically significant elevation in the phage/bacteria ratio To evaluate the implication of the increase in the phage/bacteria ratio as a driving force 225 behind E. coli depletion further, we analyzed which phages had a correlation with the depletion of 
Discussion
This study revealed an association between the dynamics of intestinal Next, we evaluated the diabetogenic potential of E.coli prophages by the fact that their induction 335 (that modulated an elevated E.coli phage/E.coli ratio from microbiome analysis) could 336 contribute to the release of bacterial amyloid (Nanda et al., 2015) . We have determined that in 337 vitro activation of E.coli prophages with mytomicin C results in the pronounced amyloid release 338 from preformed microbial biofilms, which according to data from metagenomics analysis, 339 suggests that the same process occurs in the gut of those children who further develop 340 autoimmunity and T1D (Reyrolle et al., 1982) .
341
For E. coli-derived gut amyloid to activate either one of the above signaling pathways 
